New horizons for primary intracerebral hemorrhage treatment: Experience from preclinical studies

Jaroslaw Aronowski, Christiana E. Hall

Research output: Contribution to journalArticle

207 Citations (Scopus)

Abstract

Intracerebral hemorrhage (ICH) remains a major medical problem, for which there is no effective treatment. However, extensive experimental and clinical research carried out in recent years has brought to light new exciting ideas for novel potential treatments. First, it was well documented that the management of hypertension helps to prevent new and recurrent ICH. Also, development of new guidelines for management of hypertension after the onset of the ICH may help in more effective ICH treatment. Existing contemporary data collected from preclinical studies indicates that ICH-induced inflammation represents a key factor leading to secondary brain damage, suggesting that some anti-inflammatory approaches can be used to treat hemorrhagic stroke. In this article, beyond discussing implications related to hypertension, we will summarize important (but not all) new discoveries connecting the role of inflammation to ICH pathology. Selected aspects of inflammatory response including the role of cytokines, transcription factor nuclear factor-κB, microglia activation, astrogliosis, and complement activation will be introduced. We will also discuss the role for reactive oxygen species and metalloproteinases in ICH pathogenesis and introduce basic knowledge on the nature of ICH-induced cell death including apoptosis. Potential targets for intervention and translation will be discussed.

Original languageEnglish (US)
Pages (from-to)268-279
Number of pages12
JournalNeurological Research
Volume27
Issue number3
DOIs
StatePublished - Apr 2005

Fingerprint

Cerebral Hemorrhage
Hypertension
Inflammation
Complement Activation
Microglia
Metalloproteases
Reactive Oxygen Species
Cell Death
Anti-Inflammatory Agents
Transcription Factors
Stroke
Guidelines
Apoptosis
Pathology
Cytokines
Brain
Research

Keywords

  • Cytokines
  • Hypertension
  • Inflammation
  • Intracerebral hemorrhage

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

New horizons for primary intracerebral hemorrhage treatment : Experience from preclinical studies. / Aronowski, Jaroslaw; Hall, Christiana E.

In: Neurological Research, Vol. 27, No. 3, 04.2005, p. 268-279.

Research output: Contribution to journalArticle

@article{be04ba9225d845e3aa0ac9c1826aff06,
title = "New horizons for primary intracerebral hemorrhage treatment: Experience from preclinical studies",
abstract = "Intracerebral hemorrhage (ICH) remains a major medical problem, for which there is no effective treatment. However, extensive experimental and clinical research carried out in recent years has brought to light new exciting ideas for novel potential treatments. First, it was well documented that the management of hypertension helps to prevent new and recurrent ICH. Also, development of new guidelines for management of hypertension after the onset of the ICH may help in more effective ICH treatment. Existing contemporary data collected from preclinical studies indicates that ICH-induced inflammation represents a key factor leading to secondary brain damage, suggesting that some anti-inflammatory approaches can be used to treat hemorrhagic stroke. In this article, beyond discussing implications related to hypertension, we will summarize important (but not all) new discoveries connecting the role of inflammation to ICH pathology. Selected aspects of inflammatory response including the role of cytokines, transcription factor nuclear factor-κB, microglia activation, astrogliosis, and complement activation will be introduced. We will also discuss the role for reactive oxygen species and metalloproteinases in ICH pathogenesis and introduce basic knowledge on the nature of ICH-induced cell death including apoptosis. Potential targets for intervention and translation will be discussed.",
keywords = "Cytokines, Hypertension, Inflammation, Intracerebral hemorrhage",
author = "Jaroslaw Aronowski and Hall, {Christiana E.}",
year = "2005",
month = "4",
doi = "10.1179/016164105X25225",
language = "English (US)",
volume = "27",
pages = "268--279",
journal = "Neurological Research",
issn = "0161-6412",
publisher = "Maney Publishing",
number = "3",

}

TY - JOUR

T1 - New horizons for primary intracerebral hemorrhage treatment

T2 - Experience from preclinical studies

AU - Aronowski, Jaroslaw

AU - Hall, Christiana E.

PY - 2005/4

Y1 - 2005/4

N2 - Intracerebral hemorrhage (ICH) remains a major medical problem, for which there is no effective treatment. However, extensive experimental and clinical research carried out in recent years has brought to light new exciting ideas for novel potential treatments. First, it was well documented that the management of hypertension helps to prevent new and recurrent ICH. Also, development of new guidelines for management of hypertension after the onset of the ICH may help in more effective ICH treatment. Existing contemporary data collected from preclinical studies indicates that ICH-induced inflammation represents a key factor leading to secondary brain damage, suggesting that some anti-inflammatory approaches can be used to treat hemorrhagic stroke. In this article, beyond discussing implications related to hypertension, we will summarize important (but not all) new discoveries connecting the role of inflammation to ICH pathology. Selected aspects of inflammatory response including the role of cytokines, transcription factor nuclear factor-κB, microglia activation, astrogliosis, and complement activation will be introduced. We will also discuss the role for reactive oxygen species and metalloproteinases in ICH pathogenesis and introduce basic knowledge on the nature of ICH-induced cell death including apoptosis. Potential targets for intervention and translation will be discussed.

AB - Intracerebral hemorrhage (ICH) remains a major medical problem, for which there is no effective treatment. However, extensive experimental and clinical research carried out in recent years has brought to light new exciting ideas for novel potential treatments. First, it was well documented that the management of hypertension helps to prevent new and recurrent ICH. Also, development of new guidelines for management of hypertension after the onset of the ICH may help in more effective ICH treatment. Existing contemporary data collected from preclinical studies indicates that ICH-induced inflammation represents a key factor leading to secondary brain damage, suggesting that some anti-inflammatory approaches can be used to treat hemorrhagic stroke. In this article, beyond discussing implications related to hypertension, we will summarize important (but not all) new discoveries connecting the role of inflammation to ICH pathology. Selected aspects of inflammatory response including the role of cytokines, transcription factor nuclear factor-κB, microglia activation, astrogliosis, and complement activation will be introduced. We will also discuss the role for reactive oxygen species and metalloproteinases in ICH pathogenesis and introduce basic knowledge on the nature of ICH-induced cell death including apoptosis. Potential targets for intervention and translation will be discussed.

KW - Cytokines

KW - Hypertension

KW - Inflammation

KW - Intracerebral hemorrhage

UR - http://www.scopus.com/inward/record.url?scp=17144403822&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17144403822&partnerID=8YFLogxK

U2 - 10.1179/016164105X25225

DO - 10.1179/016164105X25225

M3 - Article

C2 - 15845210

AN - SCOPUS:17144403822

VL - 27

SP - 268

EP - 279

JO - Neurological Research

JF - Neurological Research

SN - 0161-6412

IS - 3

ER -